In conclusion, a combination of L-FABP levels and SOFA scores can improve the efficiency and accuracy of pre-admission screening for patients with COVID-19, potentially reducing unnecessary hospital admissions and optimizing resource allocation. This evidence concerns the gene FABP1 and COVID-19.